Filed by the Registrant ☑
|
Filed by a Party other than the Registrant ☐
|
☑ |
Preliminary Proxy Statement
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐ |
Definitive Proxy Statement
|
☐ |
Definitive Additional Materials
|
☐ |
Soliciting Material under §240.14a-12
|
(Name of Registrant as Specified in its Charter)
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
☑ |
No fee required.
|
☐ |
Fee paid previously with preliminary materials.
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|


PRELIMINARY PROXY STATEMENT DATED APRIL 18, 2025
SUBJECT TO COMPLETION
![]() ADAM GOLDSTEIN
Founder & Chief Executive Officer
TO OUR STOCKHOLDERS:
You are cordially invited to attend the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Archer
Aviation Inc., which will be held virtually at www.virtualshareholdermeeting.com/ACHR2025 on Friday, June 27, 2025, 12:00 p.m. Pacific Time. The Annual Meeting will be held in a virtual meeting format only. We believe that
a virtual stockholder meeting provides greater access to those who wish to attend and therefore we have chosen this format.
The matters expected to be acted upon at the Annual Meeting are described in the accompanying Notice of Annual
Meeting of Stockholders (the “Notice”) and Proxy Statement (the “Proxy Statement”). The Annual Meeting materials include the Notice, the Proxy Statement, our annual report, and proxy card.
Your vote is important. Whether or not you plan to attend the Annual Meeting virtually, please cast your vote as
soon as possible by Internet, telephone or, if you received a paper proxy card and voting instructions by mail, by completing and returning the enclosed proxy card in the postage-prepaid envelope to ensure that your shares
will be represented. Your vote by written proxy will ensure your representation at the Annual Meeting regardless of whether you attend virtually. Returning the proxy does not affect your right to attend the Annual Meeting
virtually or to vote your shares virtually during the Annual Meeting.
Sincerely
![]() |
Your vote is
important.
Whether or not
you plan to
attend the
annual
meeting, please
cast your vote
as soon as
possible by
internet,
telephone,
or by mail.
|
|

Date and Time
|
Virtual Meeting Site
|
Who Can Vote
|
June 27, 2025, 12:00 p.m. Pacific Time
|
www.virtualshareholdermeeting.com/ACHR2025
|
Stockholders of record at the close of business on April 28, 2025
|
Agenda Item
|
Board Vote Recommendation
|
1.
Elect certain directors of Archer Aviation Inc., each to serve a three-year term expiring at the 2028 annual meeting of stockholders and
until such director’s successor is duly elected and qualified
|
FOR EACH DIRECTOR
NOMINEE
|
2.
Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31,
2025
|
FOR
|
3.
Advisory vote to approve the compensation of our named executive officers
|
FOR
|
4.
Approve the issuance of 751,879 shares of Class A Common Stock to Stellantis N.V. (“Stellantis”) pursuant to that certain subscription
agreement, dated as of December 11, 2024, by and between the Company and Stellantis (the “Stellantis Subscription Agreement”)
|
FOR
|

|

Table of Contents
|
||
5
|
||
9
|
||
20
|
||
28
|
||
30
|
||
31
|
||
33
|
||
34
|
||
36
|
||
37
|
||
37
|
||
49
|
||
57
|
||
61
|
||
62
|
||
63
|
||
65
|
||
References to our websites in this Proxy Statement are not intended to function as hyperlinks and the information contained on our websites is not intended to
be incorporated into this Proxy Statement.
|
|

|

|

–
|
Single class of shares with equal voting rights.
|
–
|
Majority of directors are independent (6 out of 7 current directors).
|
–
|
Board of directors leadership structure with a Lead Independent Director that has been appointed by a majority of our independent directors. Our Lead
Independent Director has well defined rights and responsibilities.
|
–
|
All board committees are composed of independent directors.
|
–
|
Independent directors conduct regular executive sessions.
|
–
|
Board of directors has related party transaction standards for any direct or indirect involvement of a director in the Company’s business activities.
|
–
|
Each director attended at least 75% of the meetings of the board of directors and committees on which he or she served in 2024.
|
–
|
None of our directors are considered “overboarded.”
|
–
|
Comprehensive risk oversight practices, including internal controls, cybersecurity, legal and regulatory matters, compensation, and other critical evolving
areas.
|
–
|
Our Insider Trading Policy prohibits against directors, officers and employees from hedging and shorting of Archer common stock, and, except in limited
circumstances, pledging Archer common stock.
|
–
|
We have adopted and administer a robust Compensation Recovery Policy, which applies to our executive officers.
|
|

Our Board of Directors
and Nominees
|
|||
![]() |
![]() |
![]() |
![]() |
ADAM GOLDSTEIN
Co-Founder, CEO & Director
AGE: 45
SINCE: September 2021
|
DEBORAH DIAZ
Director, Chairperson,
Nominating and Corporate
Governance Committee and
Member of the Audit Committee
(Nominee for re-election)
AGE: 67
SINCE: September 2021
|
FRED M. DIAZ
Lead Independent Director,
Chairperson, Compensation
Committee and Member of the
Audit Committee
(Nominee for re-election)
AGE: 59
SINCE: September 2021
|
OSCAR MUNOZ
Director, Member of the
Compensation Committee
AGE: 66
SINCE: September 2021
|
![]() |
![]() |
![]() |
|
BARBARA PILARSKI
Director, Member of the Nominating
and Corporate Governance
Committee
AGE: 61
SINCE: January 2022
|
MARIA PINELLI
Director, Chairperson,
Audit Committee and Member of
the Compensation Committee
AGE: 62
SINCE: September 2021
|
MICHAEL SPELLACY
Director, Member of the
Nominating and Corporate
Governance Committee
AGE: 53
SINCE: September 2021
|
|

MEETING DATE
|
RECORD DATE
|
MEETING TIME
|
VIRTUAL MEETING
ACCESS
|
Friday, June 27, 2025
|
Monday, April 28, 2025
|
12:00 p.m. Pacific Time
|
www.virtualshareholdermeeting.com/ACHR2025 using your control number included on your Notice of Internet Availability of Proxy Materials
or on your proxy card
|
ONLINE
|
PHONE
|
MAIL
|
www.proxyvote.com
|
Follow instructions shown on proxy card
|
If you received paper materials, mail to: Vote Processing, c/o Broadridge Financial Solutions, Inc. 51 Mercedes Way, Edgewood, New
York 11717
|
PROPOSAL
|
BOARD
RECOMMENDATION
|
PAGE REFERENCE
|
|
Proposal 1
|
Election of directors named in this Proxy Statement
|
For each director nominee
|
20 |
Proposal 2
|
Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered
public accounting firm for the fiscal year ending December 31, 2025
|
For
|
28 |
Proposal 3
|
Advisory vote on the compensation of our named executive officers
|
For
|
30 |
Proposal 4
|
Approval of share issuance to Stellantis pursuant to Stellantis Subscription Agreement
|
For
|
31 |
|

One share equals one vote
|
We have a single class of shares with equal voting power.
|
||
Separation of Lead Independent Director and CEO roles
|
Our CEO is focused on managing Archer and our Lead Independent Director drives accountability at the board of directors level.
|
||
Access to management
|
Our board of directors has significant interaction with senior management and access to other employees.
|
||
Succession planning
|
Our nominating and corporate governance committee regularly discusses board of directors and executive succession planning.
|
||
Executive sessions
|
All quarterly board of directors and committee meetings include executive sessions.
|
||
Board, committee and individual self-evaluations
|
Our directors conduct annual performance self-evaluations of our board of directors and each committee of which each director is a
member.
|
|

– |
presiding at all meetings of the board of directors at which the CEO is not present or when the
performance of our board of directors or CEO is discussed;
|
– |
acting as a liaison between the independent directors and the CEO;
|
– |
convening meetings of the independent directors as appropriate;
|
– |
consulting with the CEO in planning and setting schedules and agendas for meetings of the board of directors;
|
– |
being available for consultation and direct communication with stockholders as appropriate; and
|
– |
performing such other functions as the board of directors may delegate.
|
NAME | AUDIT COMMITTEE |
COMPENSATION
COMMITTEE
|
NOMINATING AND
CORPORATE
GOVERNANCE
COMMITTEE
|
|
Deborah Diaz
|
● | ![]() |
||
Fred M. Diaz
|
● | ![]() |
||
Oscar Munoz
|
● | |||
Barbara Pilarski
|
● | |||
Maria Pinelli
|
![]() |
● | ||
Michael Spellacy
|
● | |||
Number of meetings
|
5 |
6 |
4 |
|
● Member |
![]() |
|

–
|
reviewing and discussing with management our quarterly and annual financial results, earnings guidance, and earnings press releases prior to distribution to
the public;
|
–
|
selecting, appointing, compensating and overseeing the work of the independent registered public accounting firm;
|
–
|
reviewing the qualification, performance and continuing independence of the independent registered public accounting firm;
|
–
|
discussing the scope and results of the audit with the independent registered public accounting firm and reviewing, with management and that firm, our
interim and annual financial results;
|
–
|
establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing
matters, and for the confidential and anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;
|
–
|
overseeing our internal audit function;
|
–
|
overseeing and considering the effectiveness of our internal controls;
|
–
|
reviewing proposed waivers of the code of conduct for directors, executive officers, and employees (with waivers for directors or executive officers to be
approved by the board of directors);
|
–
|
reviewing with management the company’s significant risks, reviewing our policies for risk assessment and risk management, with respect to internal controls
around financial reporting, and steps management has taken to monitor or mitigate these risks;
|
–
|
overseeing our risk assessment and management, including with respect to risks and incidents related to cybersecurity;
|
–
|
reviewing and approving or ratifying related party transactions that are material or otherwise implicate disclosure requirements; and
|
–
|
approving or, as permitted, pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm.
|
–
|
reviewing and approving the compensation and the terms of any compensatory agreements of our executive officers;
|
–
|
reviewing and recommending to our board of directors the compensation of our non-employee directors;
|
–
|
reviewing and approving the selection of our peer companies for compensation assessment purposes;
|
–
|
administering our equity incentive compensation plans;
|
–
|
reviewing our compensation-related risk exposures and management’s mitigation measures;
|
–
|
reviewing succession plans for senior management positions, including our CEO;
|
–
|
reviewing and approving, or making recommendations to our board of directors, with respect to, incentive compensation and equity plans; and
|
–
|
establishing our overall compensation philosophy.
|
|

–
|
identifying and recommending candidates for membership on our board of directors;
|
–
|
recommending directors to serve on board committees;
|
–
|
advising the board on certain corporate governance matters;
|
–
|
developing policies regarding director nomination processes, if and as the committee determines it appropriate to have such policies;
|
–
|
establishing procedures for the receipt, retention and treatment of complaints received by us regarding violations of company policies or law, including the
confidential and anonymous submission by our employees of concerns regarding any conduct that may violate company policies or law;
|
–
|
developing and overseeing any program relating to corporate responsibility and sustainability, including environmental, social, and corporate governance
matters and related risks, controls, and procedures; and
|
–
|
overseeing the evaluation of our board of directors and its committees.
|
OUR BOARD OF DIRECTORS’ OVERSIGHT OF RISK
Committee
|
Primary Areas of Risk Oversight
|
||
Audit
|
• Oversee financial reporting process, accounting policies and internal controls
• Evaluate risks related to financial reporting, accounting, auditing, tax and fraud
• Evaluate exposures and risks related to cybersecurity and other information
security policies and practices and related internal controls, and monitoring, assessing and reporting such exposures
|
||
Compensation
|
• Oversee compensation plans, programs and policies
• Evaluate major compensation- and human capital-related risk exposures and
monitoring of such exposures
• Evaluate and provide input on CEO and senior management succession planning
|
||
Nominating and Corporate
Governance |
• Review and evaluate the corporate governance framework, including governance
guidelines and policies
• Evaluate the structure and composition of our board of directors and committees and role in risk oversight
• Oversee the corporate social responsibility program and initiatives
|
|

|

|

●
|
Aircraft Safety Engineering - Applying what we believe to be current civil aviation best practices to identify
potential hazards and develop designs that incorporate sound safety features;
|
●
|
Design Integrity - Establishing requirements-based engineering methods including validation and verification, as well
as internal, supplier, and third-party audits;
|
●
|
Production Safety and Quality - End-to-end tracking of every aircraft part, strict configuration control, and a full
record of any identified production defect from discovery to resolution;
|
●
|
Flight Safety - A systematic risk management process from the release of each aircraft for flight operations, to
clearing each flight test and then followed by a detailed flight briefing;
|
●
|
Safety Culture - Focusing on ensuring a safe work environment for employees and developing policies and cultivating
leadership attitudes and behaviors that promote a healthy safety culture across Archer.
|
|

The board of directors has adopted a non-employee director compensation policy designed to align compensation with our business objectives and the creation of stockholder value, while enabling us to attract and retain directors to contribute to our long-term success.
NAME
|
FEES EARNED OR PAID IN
CASH ($)(1)
|
STOCK AWARDS ($)(2)
|
TOTAL ($)
|
Deborah Diaz
|
158,000
|
199,997
|
357,997
|
Fred M. Diaz
|
190,000
|
199,997
|
389,997
|
Oscar Munoz
|
146,000
|
199,997
|
345,997
|
Barbara Pilarski (3)
|
—
|
—
|
—
|
Maria Pinelli
|
161,000
|
199,997
|
360,997
|
Michael Spellacy
|
144,000
|
199,997
|
343,997
|
(1) Amounts reflect cash retainer amounts received by our non-employee directors for service on our board of directors, including committee and/or chairpersonship
fees, and, in the case of Mr. Diaz, fees associated with serving as Lead Independent Director.
|
|||
(2) Amounts reflect the aggregate grant date fair value of the RSUs measured pursuant to Financial Accounting Standards Board Accounting Standard Codification
Topic 718 (“ASC 718”), without regard to forfeitures. The assumptions used in calculating the grant date fair value of these awards are set forth in Note 9 to our Notes to the Consolidated Financial Statements included on our
Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025. These amounts do not reflect the actual economic value that may be realized by the non-employee director.
|
|||
(3) Ms. Pilarski has agreed to waive her director compensation with respect to her service as a non-employee director until such time as she is no longer employed
by Stellantis or any of its affiliates.
|
NAME
|
NUMBER OF SHARES
UNDERLYING RSUS GRANTED
IN 2024 (1) |
NUMBER OF SHARES
UNDERLYING UNVESTED
RSUS HELD AT FISCAL YEAR
END |
Deborah Diaz
|
54,644
|
54,644
|
Fred M. Diaz (2)
|
54,644
|
54,644
|
Oscar Munoz (3)
|
54,644
|
54,644
|
Barbara Pilarski
|
—
|
—
|
Maria Pinelli
|
54,644
|
54,644
|
Michael Spellacy
|
54,644
|
54,644
|
(1) The shares of Class A common stock underlying these awards vest or have vested as to 54,644 shares of Class A common stock, in full on the earlier of June 21,
2025 and the date of the Annual Meeting.
|
|

–
|
Initial Equity Grant. Each non-employee director is granted an equity award, in the form of RSUs, on the date of
their appointment to our board of directors having an aggregate value of $200,000 based on the closing price of our Class A common stock on the date of grant (the “Initial Equity Grant”). New non-employee directors appointed to
our board of directors on a date other than our annual meeting of stockholders will be provided a prorated Initial Equity Grant based on the full number of months until the next annual meeting of stockholders. The Initial Equity
Grant will vest on the earlier of (i) the date of the next annual meeting of the company’s stockholders and (ii) the date that is one year following the Initial Equity Grant date, in each case, so long as the non-employee
director continues to provide services to the company through such date. Each Initial Equity Grant will accelerate in full upon the consummation of a Corporate Transaction (as defined in our 2021 Plan), subject to the
non-employee director providing continuous service to the company through the applicable Corporation Transaction, or upon the applicable non-employee director’s death or Disability (as defined in the 2021 Plan).
|
–
|
Annual Equity Grant. On the date of each annual meeting of stockholders, each non-employee director who is serving
on our board of directors, and who will continue to serve on our board of directors immediately following the date of such annual meeting, will automatically be granted equity, in the form of RSUs, having an aggregate value of
$200,000 based on the closing price of our Class A common stock on the date of grant (the “Annual Equity Grant”). Each Annual Equity Grant will vest on the earlier of (i) the date of the next annual meeting of the company’s
stockholders and (ii) the date that is one year following the Annual Equity Grant date, in each case, so long as the non-employee director continues to provide services to the company through such date. Each Annual Equity Grant
will accelerate in full upon the consummation of a Corporate Transaction, subject to the non-employee director providing continuous service to the company through the applicable Corporation Transaction, or upon the applicable
non-employee director’s death or Disability.
|
|

|

|

1 ELECTION OF DIRECTORS
|
Our board of directors recommends a vote FOR the election of Deborah Diaz and Fred Diaz.
|
|

INFORMATION ABOUT OUR BOARD OF DIRECTORS AND NOMINEES
NAME
|
AGE
|
POSITION
|
DIRECTOR SINCE
|
Deborah Diaz(1)(2)
|
67
|
Director
|
September 2021
|
Fred Diaz(2)(3)(4)
|
59
|
Director
|
September 2021
|
(1) |
Chair of the nominating and corporate governance committee
|
(2) |
Member of the audit committee
|
(3) |
Chair of the compensation committee
|
(4) |
Lead independent director
|
|

![]() DEBORAH DIAZ
DIRECTOR
AGE: 67
DIRECTOR SINCE:
September 2021
COMMITTEES:
Nominating and Corporate
Governance (Chair)
Audit
|
Ms. Diaz has served as a member of our board of directors and audit committee and as the Chair of the nominating
and corporate governance committee since September 2021. As CEO and VC Advisor of Catalyst ADV, Ms. Diaz manages a strategic growth advisory firm specializing in business transformation, innovative technologies, advanced
manufacturing and strategic partnerships since December 2016. Ms. Diaz served as National Aeronautics and Space Administration’s (“NASA”) Chief Technology Officer and Deputy Chief Information Officer from November 2009 to
October 2016, where she was responsible for NASA’s global system infrastructure, technology pilots, and risk management. From January 2007 to November 2009, Ms. Diaz served as Deputy Chief Information Officer for the United
States Patent and Trademark Office. From October 2002 to January 2007, Ms. Diaz was the Senior Technical Advisor to create the U.S. Department of Homeland Security and also the Chief Information Officer for Science and
Technology. Ms. Diaz brings decades of experience with industry and international organizations overseeing large operational staffs and budget, ESG implementation, and global business joint ventures. Ms. Diaz currently serves
on the board of directors of Section IO and on the advisory board of directors of Equinix and Intel Corporation. Ms. Diaz formerly served on the board of directors of Dell Technologies GAB, Forcepoint EAB, Battle Resource
Management, Inc., Intelvative, Inc., eKuber Ventures, Lincolnia LLC and ZeroAvia Inc.
SKILLS & EXPERIENCE
Ms. Diaz is National Association of Corporate Directors “Directorship” and Directors Academy “Board Director”
certified. She holds an M.S. in International Business from Colorado State University and B.S. in Business Administration from Stonehill College. Ms. Diaz is also a licensed single engine pilot. We believe that Ms. Diaz’s
broad experience working with innovative technologies and leadership in multiple high-risk market evolutions in both the private sector and government qualify her to serve on our board.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– Primis Financial Corp.
|
|

![]() FRED M. DIAZ
LEAD INDEPENDENT
DIRECTOR
AGE: 59
DIRECTOR SINCE:
September 2021
COMMITTEES:
Compensation (Chair)
Audit
|
Mr. Diaz has served as a member of our board of directors since September 2021. Mr. Diaz served as President, CEO and
Chairman of the Board of Mitsubishi Motors North America from April 2018 to April 2020. Before that, Mr. Diaz served as General Manager in Charge, Performance Optimization Global Marketing and Sales of Mitsubishi Motors
Corporation in Japan, from July 2017 to April 2018. From April 2013 to July 2017, Mr. Diaz served in a number of roles for Nissan Motor Corporation, including Division Vice President & General Manager—North American Trucks
and Light Commercial Vehicles, Sr. Vice President Sales, Marketing, Product Planning and Operations, and Division Vice President, Sales, Marketing, Product Planning and Parts & Service. Mr. Diaz also served in several
roles for Fiat Chrysler Automobiles from 2004 to 2013, including President and CEO Ram Truck Brand, President and CEO Chrysler Mexico, Head of National Sales and National Director of Marketing Communications.
SKILLS & EXPERIENCE
Mr. Diaz holds a B.S. in Business Administration and Management with a Minor in Psychology from Texas Lutheran
University and an M.B.A. from Central Michigan University. We believe that Mr. Diaz’s executive experience in various CEO and C-suite leadership roles as well as his robust sales, marketing, operations and product planning
background in the automotive industry qualify him to serve on our board.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– Valero Energy Corporation
– Smith & Wesson Brands, Inc.
– Site One Landscape Supply Inc. (f/k/a as John Deere Landscapes LLC)
|
|

NAME
|
AGE
|
POSITION
|
CLASS
|
DIRECTOR SINCE
|
Barbara Pilarski(1)
|
61
|
Director
|
Class II
|
January 2022
|
Maria Pinelli(2)(3)
|
62
|
Director
|
Class II
|
September 2021
|
Michael Spellacy(1)
|
53
|
Director
|
Class II
|
September 2021
|
Adam Goldstein
|
45
|
Director
|
Class III
|
September 2021
|
Oscar Munoz(3)
|
66
|
Director
|
Class III
|
September 2021
|
(1) |
Member of the nominating and corporate governance committee
|
(2) |
Chair of the audit committee
|
(3) |
Member of the compensation committee
|
|

![]() ADAM GOLDSTEIN
FOUNDER, CEO AND
DIRECTOR
AGE: 45
DIRECTOR SINCE:
September 2021
COMMITTEES:
None
|
Mr. Goldstein is Archer’s founder and serves as our CEO. From September 2021 to April 2022, Mr. Goldstein served as our
Co-CEO and Co-Chairperson of our board of directors. Prior to the go-public transaction, Mr. Goldstein served as the President and CEO of Archer and a member of its board of directors. Prior to founding Archer, Mr. Goldstein also
co-founded and led Vettery from November 2012 to December 2019. Before Vettery, Mr. Goldstein served as Co-Managing Partner of Minetta Lane Capital Partners from March 2011 to August 2012. From February 2011 to November 2019 Mr.
Goldstein served as Portfolio Manager at Plural Investments and from September 2005 to October 2009 Mr. Goldstein served as a Senior Analyst at Cedar Hill Capital Partners. Mr. Goldstein currently serves on the board of trustees of
the Museum of American Finance.
SKILLS & EXPERIENCE
Mr. Goldstein holds a B.S. in Business Administration from the University of Florida and an M.B.A. from NYU Stern School
of Business. We believe that Mr. Goldstein’s role as co-founder and Chief Executive Officer and his extensive insight into Archer qualify him to serve on our board.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– None
|
![]() OSCAR MUNOZ
DIRECTOR
AGE: 66
DIRECTOR SINCE:
September 2021
COMMITTEES:
Compensation
|
Mr. Munoz has served as a member of our board of directors since September 2021. Mr. Munoz served as Chairman and CEO
of United Airlines from September 2015 to May 2021. He also served as a member of the board of directors of United Continental Holdings, Inc. from October 2010 to June 2021. Before joining United’s executive team, Mr. Munoz served
in several roles at CSX Corporation from May 2003 to September 2015, including President, COO, CFO, and Executive Vice President. Mr. Munoz previously served on the board of directors of Continental Airlines, Inc. from May 2004
until its acquisition by United Airlines in October 2010. From January 2001 to April 2003, Mr. Munoz served as CFO of Consumer Services at AT&T. Before that, Mr. Munoz served as SVP of Finance and Administration at U.S. West
from July 1997 to December 2000. Mr. Munoz also served in various leadership roles for The Coca-Cola Company from June 1986 to June 1997 and for PepsiCo from June 1982 to June 1986. Mr. Munoz currently serves on the board of
directors of Univision Communications Inc. as well as an independent trustee on Fidelity Investments’ Equity & High-Income Fund. Mr. Munoz also currently serves on the board of trustees of the University of Southern California
and The Brookings Institution.
SKILLS & EXPERIENCE
Mr. Munoz holds a B.A. in Finance and Strategy from USC’s Marshall School of Business and an MBA from Pepperdine
University. We believe that Mr. Munoz’s deep understanding of the airline and transportation industries and executive experience at complex multi-national businesses qualify him to serve on our board.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– CBRE Group, Inc.
– Salesforce.com, Inc.
|
|

![]() BARBARA PILARSKI
DIRECTOR
AGE: 61
DIRECTOR SINCE:
January 2022
COMMITTEES:
Nominating and Corporate
Governance
|
Ms. Pilarski has served as a member of our board of directors since January 2022. Ms. Pilarski currently serves as Global
Head of Business Development at Stellantis, a position she has occupied since March 2021. Prior to joining Stellantis, Ms. Pilarski was employed at FCA US LLC (“FCA”) since 2009, having served as Head of Business Development for the
North America region from March 2019 to February 2021, Head of Human Resources for the North America region from September 2017 to March 2019, and Head of Business Development for the North America region from June 2009 to September
2017. Prior to her employment at FCA, Ms. Pilarski served in various business development and finance positions within Chrysler LLC, DaimlerChrysler Corporation, and Chrysler Corporation since September 1985. Ms. Pilarski is the
Executive Sponsor of the Stellantis Women’s Business Resource Group, which is dedicated to pursuing the professional development and advancement of female employees. Mrs. Pilarski currently serves on the board of directors of Corewell
Health.
SKILLS & EXPERIENCE
Ms. Pilarski has a B.S. in Business Administration from Wayne State University and an M.B.A. from the University of
Michigan. We believe that Ms. Pilarski’s leadership and business development roles at international companies and extensive experience in transportation and manufacturing qualify her to serve on our board.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– None
|
![]() MARIA PINELLI
DIRECTOR
AGE: 62
DIRECTOR SINCE:
September 2021
COMMITTEES:
Audit (Chair)
Compensation
|
Ms. Pinelli has served as a member of our board of directors since September 2021. Ms. Pinelli has served as the Chief
Executive Officer of Strategic Growth Advisors, LLC since December 2020. From July 2017 to December 2020, Ms. Pinelli led Ernst & Young LLP’s (“EY”) Consumer Products and Retail sector. From July 2011 to June 2017, Ms. Pinelli was
a Global Vice Chair of EY and led EY’s Global Strategic Growth Business unit with a focus on serving entrepreneurs, private and public companies poised for exponential growth. During the same period, she also served as EY’s Global IPO
Leader, helping clients prepare for the public markets including initial public offering readiness, Sarbanes-Oxley Act compliance and how to manage stakeholder expectations. Prior to leading this global business of EY, Ms. Pinelli was
EY’s Americas Director of Strategic Growth Markets from 2006 to 2011. She has led more than 20 IPOs in four different countries, more than 25 M&A transactions worldwide and speaks fluently on the capital markets, and has testified
as an expert before the U.S. Financial Services Committee.
SKILLS & EXPERIENCE
Ms. Pinelli holds a B.Com. in Commerce from McMaster University and is a CPA in the United Kingdom and Canada. We believe
that Ms. Pinelli is well-qualified to serve on our board due her international business and leadership roles, professional experience in the areas of finance, accounting, and audit oversight and her extensive experience in advising
growth companies.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– Globant S.A.
– International Game Technology PLC
|
|

![]() MICHAEL SPELLACY
DIRECTOR
AGE: 53
DIRECTOR SINCE:
September 2021
COMMITTEES:
Nominating and Corporate Governance
|
Mr. Spellacy has served as a member of our board of directors since September 2021. Mr. Spellacy has served as Managing
Director of Alvarez & Marsal, LLC since June 2023. From October 2020 to June 2023, Mr. Spellacy served as CEO and director of Atlas Crest Investment Corporation. He served as a Senior Managing Director at Accenture plc
(“Accenture”) from December 2017 to October 2020 and as Global Industry Leader of Accenture Capital Markets business overseeing Accenture’s Asset Management, Wealth Management and Investment and Trading businesses. Prior to
Accenture, Mr. Spellacy was a Senior Partner, Asset and Wealth Management, at PricewaterhouseCoopers LLP from 2015 to 2017 and prior to that role, Mr. Spellacy was a Partner at Broadhaven Capital, an industry leading independent
investment bank and private equity investor servicing the financial services and technology sectors from 2013 to 2015. Prior to Broadhaven, Mr. Spellacy was a Senior Executive, Management Committee Advisor at Bridgewater Associates, a
widely recognized asset manager from 2009 to 2013. Prior to Bridgewater, Mr. Spellacy was a Partner and Managing Director at the Boston Consulting Group from 2003 to 2009 where he helped guide the firm’s global Alternative Investments
Practice providing strategic business advisory services to global asset managers, sovereign wealth funds and asset owners. Mr. Spellacy’s extensive experience in technology and capital markets, as well as a public company director,
qualifies him to serve on our board.
SKILLS & EXPERIENCE
Mr. Spellacy received his B.S. in Economics from the London School of Economics and MBA from the University of Hartford.
We believe that Mr. Spellacy’s deep investing and capital markets expertise, along with his extensive management experience qualify him to serve on our board.
OTHER CURRENT PUBLIC BOARD DIRECTORSHIPS
– Enfusion, Inc.
|
|

2 RATIFICATION OF APPOINTMENT OF INDEPENDENT
THE REGISTERED PUBLIC ACCOUNTING FIRM
|
FISCAL YEAR ENDED 12/31/24($)
|
FISCAL YEAR ENDED 12/31/23 ($)
|
|
Audit Fees (1)
|
2,423,000
|
2,814,109
|
Audit Related Fees
|
—
|
—
|
Tax Fees
|
—
|
—
|
All Other Fees (2)
|
2,000
|
900
|
Total Fees
|
2,425,000
|
2,815,009
|
(1) “Audit fees” include fees for audit services primarily related to the audit of our annual consolidated financial statements and the
effectiveness of our internal control over financial reporting; the review of our quarterly consolidated financial statements; comfort letters, consents and assistance with and review of documents filed with the SEC; and other
accounting and financial reporting consultation and research work billed as audit fees or necessary to comply with the standards of the Public Company Accounting Oversight Board (United States). The total amounts in 2024 reflected
in this row includes: (i) $1,828,000 in fees for professional services rendered for the audit and review of our financial statements in connection with our required periodic filings and (ii) $595,000 in fees for professional
services rendered in connection with financial statements incorporated in registration statements and capital markets transactions. and the total amounts in 2023 reflected in this row includes: (i) $2,489,109 in fees for
professional services rendered for the audit and review of our financial statements in connection with our required periodic filings and (ii) $325,000 in fees for professional services rendered in connection with financial
statements incorporated in registration statements and capital markets transactions.
|
||
(2) “All other fees” include fees for services other than the services reported in audit fees, audit-related fees, and tax fees.
|
|

Our board of directors recommends a vote FOR the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting
firm for the fiscal year ending December 31, 2025.
|

Our board of directors recommends a vote FOR the advisory vote approving the compensation of our named executive officers.
|

(a)
|
the common stock or securities convertible into or exercisable for common stock are issued to a director, officer, a controlling shareholder or member of a
control group or any other substantial security holder of the company that has an affiliated person who is an officer or director of the Company (each an “Active Related Party”) if the number of shares of common
stock to be issued, or if the number of shares of common stock into which the securities may be convertible or exercisable, exceeds either (i) one percent of the number of shares of common stock or (ii) one percent
of the voting power outstanding before the issuance (the “NYSE Active Related Party Cap”);
|
(b)
|
(i) the common stock to be issued has (or will have upon issuance) voting power equal to or in excess of (i) 20% of the company’s outstanding voting power, or
(ii) the number of shares of common stock to be issued is (or will be upon issuance) equal to or greater than 20% of the company’s outstanding common stock, in each case determined before such issuance (the “NYSE
20% Cap”); or
|
(c)
|
the issuance will result in a change of control of the company (the “NYSE Change of Control Provision”).
|

Our board of directors recommends a vote FOR the issuance of Class A common stock to Stellantis pursuant to the Stellantis Subscription Agreement.
|


NAME
|
AGE
|
POSITION
|
Adam Goldstein
|
45
|
Founder, CEO and Director
|
Mark Mesler
|
57
|
Chief Financial Officer
|
Priya Gupta
|
42
|
Acting Chief Financial Officer
|
Eric Lentell
|
45
|
General Counsel and Secretary
|
Tom Muniz
|
40
|
Chief Technology Officer
|
Tosha Perkins
|
43
|
Chief People and Partnerships Officer
|



– |
Adam Goldstein, our CEO;
|
– |
Mark Mesler, our Chief Financial Officer(1);
|
– |
Priya Gupta, our Acting Chief Financial Officer(2);
|
– |
Eric Lentell, our General Counsel
|
– |
Tom Muniz, our Chief Technology Officer; and
|
– |
Tosha Perkins, our Chief People and Partnerships Officer.
|

Long-term “at-risk”
performance-based
compensation
|
A portion of each of the equity awards granted to our NEOs as annual refresh grants were PSUs and therefore “at risk,” dependent on relative total stockholder return, to
align the interests of our executives with our stockholders.
|
||
Annual executive
compensation review
|
Our compensation committee conducts an annual review and approval of our compensation strategy, including a review of our compensation peer group used for comparative
purposes.
|

Independent
compensation consultant
|
Our compensation committee engaged its own independent consultant, FW Cook that performs no other services for the Company other than services for the compensation committee.
|
||
Minimal perquisites and
special benefits
|
We provide limited perquisites and other personal benefits to our executives and certain senior employees. Other than a 401(k) plan, we do not provide any other retirement
benefits to employees, including our NEOs. We do not provide pension, supplemental executive health or insurance benefits.
|
||
No tax gross-ups
|
We do not provide tax gross-ups for the limited perquisites provided to our NEOs. We do not provide any tax reimbursement payments (including “gross-ups”) on any tax liability
that our executives might owe as a result of the application of Sections 280G or 4999 of the Internal Revenue Code (the “Code”).
|
||
No hedging and pledging
|
All employees, including our executive officers and members of our board of directors, are generally prohibited from hedging or pledging any Company securities or engaging in
derivative transactions.
|
||
No “single-trigger”
change-in-control
arrangements
|
Our NEOs are not eligible for payments and benefits that are payable solely as a result of a change-in-control in the Company. All change-in-control payments and benefits are
based on a “double-trigger” arrangement (that is, they require both a change-in-control of our Company plus an involuntary termination of employment before payments and benefits are paid). In addition, certain of our
performance equity awards will convert to time-based vesting on a change-in-control.
|
||
Clawback arrangements
|
We have adopted a clawback policy that requires the disgorgement of certain amounts of erroneously awarded incentive-based compensation.
|
||
Annual compensation risk
assessment
|
Our compensation committee oversees an annual risk assessment of our compensation programs.
|
||
Say-on-pay vote
|
We are holding an annual advisory vote on the compensation of our NEOs.
|
||
Equity granting policy
|
We maintain an equity granting policy, which is
reviewed by the compensation committee annually.
|

● |
market capitalization: between 0.25 to 4.0 times that of the Company
|
● |
revenue: comparability across annual revenue, not exceeding $1 billion in the past four quarters
|
● |
industry: high tech hardware and emerging technology companies
|

2024 Peer Group
|
||
Ambarella
|
Cohu |
Power Integrations
|
Aurora Innovation
|
Impinj |
QuantumScape
|
Bloom Energy
|
Joby Aviation
|
Rambus
|
Calix
|
Luminar Technologies
|
Shoals Technologies
|
ChargePoint
|
Novanta
|
Stem |
2025 Peer Group
|
||
Ambarella
|
Cohu | LiveWire |
Aurora Innovation
|
Eve
|
Luminar Tech
|
Bloom Energy
|
Evolv Technologies
|
Navitas Semiconductor
|
Calix |
Impinj
|
QuantumScape
|
ChargePoint
|
Joby Aviation
|
Stem |

Base Salary
|
Base salary is a competitive fixed element of compensation intended to attract and retain our executives, including our NEOs, and compensate
them for their day-to-day efforts. Our compensation committee reviews base salaries on an annual basis taking into account each officer’s performance, prior base salary level, competitive market data, and breadth of role, among
other factors. No NEO is entitled to any automatic base salary increases.
|
|
Performance-based Annual Cash
Bonus
|
Our annual cash bonus is a performance-based, at-risk component of our NEOs’ compensation. Variable payouts are designed to motivate and reward
our executives, including our NEOs, to perform to the best of their abilities and to achieve our corporate and the NEOs’ individual objectives.
|
|
Long-term Equity Awards
|
We use equity awards to incentivize and reward our executives (including our NEOs) for long-term corporate performance based on the value of
our Class A common stock and, thereby, to align the interests of our executives with those of our stockholders. In 2024, we continued to grant time-based RSUs to our NEOs and began granting performance-based RSUs (vesting based on
relative total stockholder return and subject to continued service to our NEOs).
|
Name
|
2024
|
2023
|
Adam Goldstein
|
750,000
|
600,000
|
Mark Mesler
|
500,000
|
500,000
|
Priya Gupta
|
338,000
|
325,000
|
Eric Lentell
|
550,000
|
500,000
|
Tom Muniz
|
700,000
|
650,000
|
Tosha Perkins
|
550,000
|
500,000
|
|

Weighting (%)
|
Corporate Goal Description
|
10
|
Manufacturing objectives
|
10
|
Flight test program objectives
|
10
|
FAA certification objectives
|
10
|
Commercialization objectives
|
10
|
Annual cash burn relative to board-approved budget
|
Name
|
Base Salary ($)
|
Target Bonus (as % of base
salary)
|
Corporate Performance
(weighted 100%)
|
Actual Bonus ($)
|
Adam Goldstein
|
750,000
|
100
|
70
|
525,000
|
Name
|
Base Salary ($)
|
Target Bonus (as % of base salary)
|
Corporate Performance (weighted 50%)
|
Individual Performance (weighted 50%)
|
Actual Bonus ($)
|
Mark Mesler (1)
|
500,000
|
50
|
70
|
100
|
146,311
|
Priya Gupta
|
338,000
|
35
|
70
|
100
|
100,555
|
Eric Lentell
|
550,000
|
50
|
70
|
100
|
233,750
|
Tom Muniz
|
700,000
|
50
|
70
|
100
|
297,500
|
Tosha Perkins
|
550,000
|
50
|
70
|
100
|
233,750
|
(1) Mr. Mesler went on temporary medical leave effective September 9, 2024 and his bonus was adjusted to reflect his length of service in 2024.
|
|

Relative TSR Percentile v. S&P 600 index
|
PSUs vesting as % of Target
|
||
90th percentile
|
200%
|
||
50th percentile
|
100%
|
||
25th percentile
|
50%
|
|

Provision
|
Grant Structure
|
Rationale
|
||
Grant Mix
|
50% PSUs based on Relative TSR and 50% RSUs based on service
|
Mix of PSUs/RSUs balances performance risk, pay-for-performance philosophy, and retention
|
||
Vesting Period
|
RSU shares vest quarterly over 3-year period, PSU shares vest annually based on each of 1-year, 2-year and 3-year Relative TSR(1)
|
Three years is standard market practice and supports critical period for strategy execution
|
||
PSU Metric
|
Based on Relative TSR from grant date
|
Aligns interests with our stockholder interests
|
(1)
|
Mr. Goldstein has elected to defer any settlement of his RSUs and PSUs to calendar year 2029 ((or, if earlier, upon his “separation from service” (as defined under Section 409A of the Code), death, disability, a change in
control of the Company, or an unforeseeable emergency (as defined under Section 409A of the Code)
|
|

|

Name
|
Number of PSUs (#)
|
||
Mark Mesler
|
63,612
|
||
Eric Lentell
|
95,420
|
||
Tom Muniz
|
95,420
|
||
Tosha Perkins
|
63,612
|
|

– |
any breach of the director’s duty of loyalty to us or our stockholders;
|
–
|
any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
|
–
|
unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL; or
|
–
|
any transaction from which the director derived an improper personal benefit.
|
|

NAME AND PRINCIPAL
POSITION
|
FISCAL
YEAR
|
SALARY
($)
|
STOCK
AWARDS
($)(1)
|
NON-EQUITY
INCENTIVE PLAN
COMPENSATION
($)(2)
|
ALL OTHER
COMPENSATION
($)(3)
|
TOTAL
($)
|
Adam Goldstein
|
2024
|
750,000
|
16,487,500
|
525,500
|
—
|
17,763,000
|
Chief Executive Officer
|
2023
|
600,000
|
—
|
393,750
|
10,000
|
1,003,750
|
2022
|
600,000
|
—
|
600,000
|
—
|
1,200,000
|
|
Mark Mesler (4)
|
2024
|
500,000
|
1,121,185
|
146,311
|
15,250
|
1,782,746
|
Chief Financial Officer
|
2023
|
500,000
|
1,083,709
|
230,000
|
15,000
|
1,828,709
|
2022
|
450,758
|
5,328,217
|
223,573
|
13,500
|
6,016,048
|
|
Priya Gupta (5)
|
2024
|
338,000
|
171,992
|
158,545
|
8,433
|
676,970
|
Acting Chief Financial Officer
|
||||||
Eric Lentell
|
2024
|
550,000
|
1,681,778
|
233,750
|
—
|
2,465,528
|
General Counsel
|
||||||
Tom Muniz
|
2024
|
700,000
|
1,681,778
|
297,500
|
8,775
|
2,688,053
|
Chief Technology Officer
|
2023
|
650,000
|
4,669,000
|
318,500
|
15,150
|
5,652,650
|
2022 |
650,000
|
— |
320,125
|
10,250
|
980,375
|
|
Tosha Perkins
|
2024 |
550,000
|
1,121,185
|
233,750
|
8,845
|
1,913,780
|
Chief People and Partnerships Officer
|
|

(1) This column shows the grant date fair value for accounting purposes of the long-term equity awards granted to our NEOs. The grant date fair
value for time-based RSUs is measured in accordance with FASB ASC 718 and based on the closing price of Archer’s common stock on the date of grant. The grant date fair value for performance-based RSUs is calculated using a
Monte-Carlo model for each award on the date of grant, as determined under FASB ASC 718, based on the probable outcome of the performance condition as of the grant date.
|
||||||
(2) The annual bonus awards are based on the performance of the Company relative to predetermined strategic goals for the year and the performance
of each individual NEO. The target payout amount for each NEO’s annual bonus payout opportunity for 2024 is shown in the table entitled “Grants of Plan-Based Awards - 2024.” Further descriptions of these amounts, including
information regarding the impact of corporate and individual performance criteria are described above in the section entitled “2024 Performance-based Annual Bonus Plan and Achievement.”
|
||||||
(3) The amounts reported represent: (a) for Mr. Goldstein, taxable reimbursement of benefit, tax, and financial advisory services (“financial
planning benefit”) of $10,000 in 2023, (b) for Mr. Mesler, company contributions under its 401(k) plan of $15,250 in 2024, $15,000 in 2023 and $13,500 in 2022, (c) for Ms. Gupta, company contributions under its 401(k) plan of $8,433
in 2024, (d) for Mr. Muniz, company contributions under its 401(k) plan of $11,500 in 2024, $11,250 in 2023 and $10,250 in 2022 and financial planning benefit of $3,900 in 2023 and (e) for Dr. Perkins, company contributions under
its 401(k) plan of $8,845 in 2024.
|
||||||
(4) Mr. Mesler went on temporary medical leave effective September 9, 2024.
|
||||||
(5) Ms. Gupta was appointed our Acting Chief Financial Officer effective as of September 9. 2024.
|
Name
|
Award
Type
|
Grant
Date
|
Estimated
Future
Payout
Under
Non-Equity
Incentive
Plan
Awards ($)
|
Estimated
Future
Payout
Under
Equity
Incentive
Plan
Awards (#) |
All Other
Stock
Awards:
Number
of
Shares
or Units
(#)
|
Grant
Date Fair
Value of
Stock
Awards
($)(1)
|
|||
Target
|
Maximum
|
Threshold
|
Target
|
Maximum
|
|||||
Adam Goldstein
|
Cash incentive
|
-
|
750,000
|
1,125,000
|
|||||
RSUs
|
12/18/24
|
750,000
|
6,712,500
|
||||||
PSUs
|
12/18/24
|
-
|
750,000
|
1,500,000
|
9,775,000
|
||||
Mark Mesler
|
Cash incentive
|
-
|
250,000
|
375,000
|
|||||
RSUs
|
3/26/24
|
95,420
|
457,062
|
||||||
PSUs
|
3/26/24
|
-
|
95,420
|
190,840
|
664,123
|
||||
Priya Gupta
|
Cash incentive
|
-
|
200,000
|
300,000
|
|||||
RSUs (2)
|
2/23/24
|
28,237
|
135,820
|
||||||
RSUs
|
5/1/24
|
42,998
|
171,992
|
Eric Lentell
|
Cash incentive
|
-
|
275,000
|
412,500
|
|||||
RSUs
|
3/26/24
|
143,130
|
685,593
|
||||||
PSUs
|
3/26/24
|
-
|
143,130
|
286,260
|
996,185
|
||||
Tom Muniz
|
Cash incentive
|
-
|
350,000
|
525,000
|
|||||
RSUs
|
3/26/24
|
143,130
|
685,593
|
||||||
PSUs
|
3/26/24
|
-
|
143,130
|
286,260
|
996,185
|
||||
Tosha Perkins
|
Cash incentive
|
-
|
275,000
|
412,500
|
|||||
RSUs
|
3/26/24
|
95,420
|
457,062
|
||||||
PSUs
|
3/26/24
|
-
|
95,420
|
190,840
|
664,123
|
(1) The grant date fair value for time-based RSUs is calculated in accordance with FASB ASC 718 based on the closing price of the Company’s
Class A common stock on the date of grant. The grant date fair value for performance-based RSUs is calculated using a Monte-Carlo model for each award on the date of grant, determined under FASB ASC 718. A discussion of the
assumptions used in calculating these values for 2024 may be found in Note 9 - Stock Based Compensation included in the notes to the consolidated financial statements in our 2024 Annual Report on Form 10-K .
|
(2) Per the Company’s policy, employees receive their annual bonus in fully vested equity and this grant reflects the annual bonus payout to Ms.
Gupta for 2023.
|
|

Option Awards
|
Stock Awards
|
|||||||||
Name
|
Grant Date
|
Number of securities underlying unexercised options exercisable (#)
|
Number of securities
underlying
unexercised
options
unexercisable (#)
|
Option
exercise price
($)
|
Option expiration date
|
Number of shares or units of stock that have not vested
(#)
|
Market value of shares of units or stock that have not vested
($)(1)
|
Number of
unearned
shares, units or other rights that have not vested
(#)
|
Market or payout value of
unearned
shares, units or other rights that have not vested
($)(1)
|
|
Adam Goldstein
|
(2)
|
9/16/2021
|
-
|
-
|
-
|
-
|
-
|
-
|
10,004,612
|
97,544,967
|
(3)
|
12/18/2024
|
750,000
|
7,312,500
|
|||||||
(4)
|
12/18/2024
|
750,000
|
7,312,500
|
|||||||
Mark Mesler
|
(5)
|
4/11/2022
|
-
|
-
|
-
|
-
|
414,196
|
4,038,411
|
-
|
-
|
(6)
|
5/1/2023
|
127,263
|
1,240,814
|
|||||||
(7)
|
3/26/2024
|
77,528
|
755,898
|
|||||||
(4)
|
3/26/2024
|
95,420
|
930,345
|
Priya Gupta
|
(8)
|
7/11/2022
|
48,712
|
474,942
|
||||||
(9)
|
5/1/2024
|
32,247
|
314,408
|
|||||||
Eric Lentell
|
(10)
|
12/8/2021
|
-
|
-
|
-
|
-
|
56,250
|
548,438
|
-
|
-
|
(11)
|
8/18/2022
|
160,062
|
1,560,605
|
|||||||
(12)
|
5/1/2023
|
178,168
|
1,737,138
|
|||||||
(13)
|
3/26/2024
|
116,292
|
1,133,847
|
|||||||
(4)
|
3/26/2024
|
-
|
-
|
-
|
-
|
143,130
|
1,395,518
|
|||
Tom Muniz
|
(14)
|
11/3/2020
|
-
|
144,621
|
0.15
|
11/2/2030
|
-
|
-
|
-
|
-
|
(15)
|
5/1/2023
|
-
|
-
|
-
|
-
|
1,437,500
|
14,015,625
|
-
|
-
|
|
(16)
|
3/26/2024
|
116,292
|
1,133,847
|
-
|
-
|
|||||
(4)
|
3/26/2024
|
143,130
|
1,395,518
|
|||||||
Tosha Perkins
|
(17)
|
4/11/2022
|
194,740
|
1,898,715
|
||||||
(18)
|
5/1/2023
|
178,168
|
1,737,138
|
|||||||
(19)
|
3/26/2024
|
77,528
|
755,898
|
|||||||
(4)
|
3/26/2024
|
95,420
|
930,345
|
|

(1) Dollar amounts shown are determined by multiplying the number of shares or units shown in the preceding column by $9.75, which was the
fair market value of the Class A common stock on December 31, 2024, the last trading day of the year. The value provided assumes any relevant performance criteria are achieved.
|
(2) On September 16, 2021, pursuant to the 2019 Plan, Mr. Goldstein was granted a performance-based equity award consisting of RSUs
settleable for 20,009,224 shares of Class B common stock. This award vests ratably in 1/4th increments upon approval by our compensation committee of the achievement of certain milestones over the seven-year period beginning on
September 16, 2021.
|
(3) On December 18, 2024, Mr. Goldstein was granted a time-based RSU award settleable for 750,000 shares of Class A common stock, pursuant to
the 2021 Plan. Subject to the terms of the award agreement, the time-based RSUs subject to this award have a three year vesting schedule, with 3/8 of the total award vesting on the date of the Annual Meeting and 1/16 of the total
award vests quarterly thereafter. Once time-vested, the RSUs will be settled for shares of the Issuer’s Class A Common Stock during calendar year 2029 on a date to be determined by the Issuer.
|
(4) Subject to the terms of the award agreement, the PSUs subject to this award are scheduled to vest on the annual anniversary of the grant
date, provided the applicable performance condition is satisfied. As described under “Executive Compensation—Compensation Discussion and Analysis,” in each case, between 0% and 200% of the target number of performance-based RSUs
may vest depending on the Company’s Relative TSR compared to the other companies in the S&P 600 during each annual performance period of the three-year award term.
|
(5) Mr. Mesler was granted a RSU settleable for 1,325,427 shares of Class A common stock on April 1, 2022 pursuant to the 2021 Plan. The
award has a four-year vesting schedule, with 1/4 vesting on March 1, 2023 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(6) Mr. Mesler was granted a RSU settleable for 226,234 shares of Class A common stock on May 1, 2023 pursuant to the 2021 Plan. The award
has a four-year vesting schedule, with 1/4 vesting on May 15, 2023 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(7) Mr. Mesler was granted a RSU settleable for 95,420 shares of Class A common stock on March 26, 2024 pursuant to the 2021 Plan. The award
has a four-year vesting schedule, with 1/16 vesting on May 15, 2024 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(8) Ms. Gupta was granted a RSU settleable for 155,875 shares of Class A common stock on July 11, 2022 pursuant to the 2021 Plan. The award
has a four-year vesting schedule, with 1/4 vesting on August 15, 2023 and 1/16 of the total award vests quarterly thereafter, subject to her continued service with us.
|
|

(9) Ms. Gupta was granted a RSU settleable for 42,998 shares of Class A common stock on May 1, 2024 pursuant to the 2021 Plan. The award has a three-year vesting schedule,
with 1/12 vesting on May 15, 2024 and 1/16 of the total award vests quarterly thereafter, subject to her continued service with us.
|
(10) Mr. Lentell was granted a RSU settleable for 300,000 shares of Class A common stock on December 8, 2021 pursuant to the 2021 Plan. The award has a four-year vesting
schedule, with 1/4 vesting on August 15, 2022 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(11) Mr. Lentell was granted a RSU settleable for 365,854 shares of Class A common stock on August 18, 2022 pursuant to the 2021 Plan. The award has a four-year vesting
schedule, with 1/4 vesting on August 15, 2023 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(12) Mr. Lentell was granted a RSU settleable for 316,742 shares of Class A common stock on May 1, 2023 pursuant to the 2021 Plan. The award has a four-year vesting schedule,
with 1/16 vesting on May 15, 2023 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(13) Mr. Lentell was granted a RSU settleable for 143,130 shares of Class A common stock on March 26, 2024 pursuant to the 2021 Plan. The award has a four-year vesting
schedule, with 1/16 vesting on May 15, 2024 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(14) Mr. Muniz was granted a stock option on November 3, 2020 pursuant to the 2019 Plan which is exercisable for 788,838 shares of the Class A common stock. The award has a
five-year vesting schedule with 1/5th of the total award vested on November 1, 2021, with 1/60th vesting ratably on a monthly basis thereafter, subject to his continued service with us. In accordance with the grant agreements
entered into by Mr. Muniz with us, he early exercised his entire stock option on November 30, 2020 and the unvested shares he received pursuant to his early exercises remain subject to a lapsing right of repurchase.
|
(15) Mr. Muniz was granted a RSU settleable for 2,300,000 shares of Class A common stock on May 1, 2023 pursuant to the 2021 Plan. The award has a four-year vesting schedule,
with 1/4 vesting on May 15, 2024 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(16) Mr. Muniz was granted a RSU settleable for 143,130 shares of Class A common stock on March 26, 2024 pursuant to the 2021 Plan. The award has a four-year vesting schedule,
with 1/16 vesting on May 15, 2024 and 1/16 of the total award vests quarterly thereafter, subject to his continued service with us.
|
(17) Dr. Perkins was granted a RSU settleable for 519,305 shares of Class A common stock on April 11, 2022 pursuant to the 2021 Plan. The award has a four-year vesting
schedule, with 1/4 vesting on May 15, 2023 and 1/16 of the total award vests quarterly thereafter, subject to her continued service with us.
|
(18) Dr. Perkins was granted a RSU settleable for 316,742 shares of Class A common stock on May 1, 2023 pursuant to the 2021 Plan. The award has a four-year vesting schedule,
with 1/16 vesting on May 15, 2023 and 1/16 of the total award vests quarterly thereafter, subject to her continued service with us.
|
(19) Dr. Perkins was granted a RSU settleable for 95,420 shares of Class A common stock on March 26, 2024 pursuant to the 2021 Plan. The award has a four-year vesting
schedule, with 1/16 vesting on May 15, 2024 and 1/16 of the total award vests quarterly thereafter, subject to her continued service with us.
|
Stock Awards
|
||
Name
|
Number of Shares Acquired on
Vesting(#)
|
Value Realized on Vesting ($)
|
Adam Goldstein
|
5,002,306
|
24,344,555
|
Mark Mesler
|
405,810
|
1,648,785
|
Priya Gupta
|
88,203
|
371,038
|
Eric Lentell
|
272,487
|
1,104,728
|
Tom Muniz
|
961,312
|
3,761,621
|
Tosha Perkins
|
301,903
|
1,224,882
|
The number of shares and value realized on vesting include shares that were withheld or sold at the time of vesting to satisfy tax withholding requirements. |
|

|

Name
|
Cash
Severance ($)
|
Continued
Health
Insurance
Coverage ($)
|
Value from
Acceleration of
Unvested
Equity Awards
($)
|
Total ($)
|
Adam Goldstein
|
||||
Upon qualifying termination - no change in control (1)
|
3,000,000
|
77,949
|
9,224,105
|
12,302,054
|
Upon qualifying termination - change in control (1)
|
3,000,000
|
77,949
|
12,187,500
|
15,265,449
|
Mark Mesler
|
||||
Upon qualifying termination - no change in control
|
750,000
|
10,687
|
1,984,583
|
2,745,270
|
Upon qualifying termination - change in control
|
1,000,000
|
10,687
|
6,655,353
|
7,666,040
|
|

Priya Gupta (2)
|
||||
Upon qualifying termination - no change in control
|
-
|
-
|
-
|
-
|
Upon qualifying termination - change in control
|
-
|
-
|
-
|
-
|
Eric Lentell
|
||||
Upon qualifying termination - no change in control
|
687,500
|
29,943
|
1,647,448
|
2,364,891
|
Upon qualifying termination - change in control
|
893,750
|
29,943
|
5,910,372
|
6,834,065
|
Tom Muniz
|
||||
Upon qualifying termination - no change in control
|
1,050,000
|
29,017
|
4,501,058
|
5,580,075
|
Upon qualifying termination - change in control
|
1,400,000
|
29,017
|
16,079,817
|
17,508,834
|
Tosha Perkins
|
||||
Upon qualifying termination - no change in control
|
825,000
|
30,318
|
1,573,738
|
2,429,056
|
Upon qualifying termination - change in control
|
1,100,000
|
60,637
|
5,011,981
|
6,172,618
|
(1) Mr. Goldstein’s offer letter provides that the unvested portion of his Founder Grant will remain outstanding and eligible to vest for a period of 15 months
post-termination.
|
||||
(2) In connection with Mr. Mesler’s leave of absence, Ms. Gupta has served as Acting Chief Financial Officer since September 2024. Ms. Gupta is not a party to a Change in
Control and Severance Agreement with the Company.
|
-
|
For 2024, the annual total compensation of the median employee of all our employees, excluding our CEO’s compensation, was $242,287.
|
-
|
The annual total compensation of our CEO in 2024 consisted of his base salary of $750,000, his performance-based cash bonus of $525,500 and the grant date fair value of $16,487,500 for the
equity awards he received in 2024 as discussed in detail above. The components of his 2024 annual compensation totaled $17,735,500
|
-
|
The ratio of our CEO’s annual total compensation in 2024 when compared to the median employee’s annual total compensation in 2024 was 73 to 1. As discussed earlier, the equity awards
our CEO received in 2024 were intended to take into account the fact that this was the first equity award he has received from the Company since it went public in 2021. As a result, our compensation committee expects
our CEO pay ratio for 2025 will be significantly lower than our CEO pay ratio for 2024. For example, the ratio of the total cash compensation paid to our CEO in 2024 and this median employee was 7:1.
|
|

Value of Initial
Fixed $100
Investment
Based on:
|
||||||||||
Year (1)
|
SCT Total
for PEO 1
($)
|
CAP to PEO
1 ($)(2)
|
SCT Total for
PEO 2 ($)
|
CAP to PEO
2 ($)(2)
|
Average
SCT Total for
non-PEO
NEOs ($)
|
Average
Compensation
Actually
Paid to
non-PEO
NEOs ($)(2)
|
TSR
$)(3)
|
Peer
Group
TSR
($)(4)
|
Net
Loss ($ millions
)(5)
|
Relative
TSR
Percentile
(%)(6)
|
2024
|
|
|
|
|
|
|
|
|
(
|
|
2023
|
|
|
|
|
|
|
|
|
(
|
|
2022
|
|
(
|
|
(
|
|
|
|
|
(
|
|
(1)
|
(2) Compensation Actually Paid reflects the exclusions and inclusions of certain amounts from the total compensation amount reported in the SCT for the PEOs and the Non-PEO
NEOs as required by Item 402(v) of Regulation S-K, as set forth in the tables below. In making each of these adjustments, the “value” of an option or stock award is the fair value of the award on the applicable date
determined in accordance with FASB ASC Topic 718 using the valuation assumptions we then used to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the
notes to our financial statements that appear in our applicable Annual Report on Form 10-K and the footnotes to the SCT that appear in our applicable definitive proxy statement.
|

PEO 1
|
|||||||||
2024 ($)
|
2023 ($)
|
2022 ($)
|
|||||||
SCT Total
|
|
|
|
||||||
- Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year
|
(
|
|
|
||||||
+ Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year
|
|
|
|
||||||
+ Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years
|
|
|
(
|
||||||
+ Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year
|
|
|
|
||||||
+ Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During
Fiscal Year
|
|
|
(
|
||||||
- Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal
Year
|
|
|
|||||||
Compensation Actually Paid
|
|
|
(
|
||||||
PEO 2
|
|||||||||
2024 ($)
|
2023 ($)
|
2022 ($)
|
|||||||
SCT Total
|
|
|
|
||||||
- Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year
|
|
|
|
||||||
+ Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year
|
|
|
|
||||||
+ Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years
|
|
|
(
|
||||||
+ Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year
|
|
|
|
||||||
+ Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During
Fiscal Year
|
|
|
(
|
||||||
- Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal
Year
|
|
|
|
||||||
Compensation Actually Paid
|
|
|
(
|
||||||
Non-PEO NEOs (average)
|
|||||||||
2024 ($)
|
2023 ($)
|
2022 ($)
|
|||||||
SCT Total |
|
||||||||
- Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year
|
(
|
( |
( |
||||||
+ Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year
|
|
||||||||
+ Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years
|
|
( |
|||||||
+ Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year
|
|
||||||||
+ Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During
Fiscal Year
|
(
|
( |
|||||||
- Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal
Year
|
|
||||||||
Compensation Actually Paid
|
|
|

(3) Archer’s TSR was determined based on the value of an initial fixed investment of $100, as of December 31, 2021, including the reinvestment of any dividends.
|
(4) The peer group used in this table is the S&P Aerospace & Defense Select Index, which is the same peer group that we use for purposes of the stock performance
graph contained in our Annual Report on Form 10-K for the year ended December 31, 2024.
|
(5) Represents the Company’s net loss reflected in the Company’s audited financial statements.
|
(6) Our Company-Selected Measure is
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|




|

PLAN CATEGORY
|
NUMBER OF SECURITIES
TO BE ISSUED UPON
EXERCISE OF
OUTSTANDING
SECURITIES (#)
|
WEIGHTED-AVERAGE
EXERCISE PRICE OF
OUTSTANDING OPTIONS
($)(1)
|
NUMBER OF SECURITIES
REMAINING AVAILABLE FOR
FUTURE ISSUANCE UNDER
EQUITY COMPENSATION PLANS
(EXCLUDING SECURITIES
REFLECTED IN COLUMN(A))(#)
|
(a)
|
(b)
|
(c)
|
|
Equity compensation plans approved by security holders (2)
|
32,141,980(3)
|
0.13
|
39,918,624(4)
|
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
Total
|
32,141,980
|
0.13
|
39,918,624
|
(1) The weighted-average exercise price does not reflect the shares that will be issued in connection with the settlement of RSUs, since RSUs have no exercise price.
|
|||
(2) Includes our (i) 2021 Plan; (ii) 2021 Employee Stock Purchase Plan; and 2019 Equity Incentive Plan (the “2019 Plan”).
|
|||
(3) Includes: (i) 20,186,233 shares subject to outstanding awards granted under the 2021 Plan, 18,567,855 shares of which shares were subject to outstanding RSU awards and
1,618,378 shares were subject to outstanding PSU awards (ii) 11,955,747 shares subject to outstanding awards granted under the 2019 Plan, of which 1,951,135 shares were subject to outstanding option awards and 10,004,612
shares were subject to outstanding RSU awards.
|
|||
(4) As of December 31, 2024, there were 31,785,442 shares of Class A common stock available for issuance under the 2021 Plan and no additional shares available for issuance
under the 2019 Plan. The number of shares of Class A common stock reserved for issuance under our 2021 Plan increased automatically by 25,191,478 shares on January 1, 2025 and will increase automatically on the first day
of January of each of 2022 through 2031 by the number of shares equal to 5% of all series and classes of our common stock outstanding as of the immediately preceding December 31 or a lower number approved by our board of
directors. As of December 31, 2024, there were 8,133,182 shares of Class A common stock available for issuance under the 2021 Employee Stock Purchase Plan. The number of shares of Class A common stock reserved for
issuance under our 2021 Employee Stock Purchase Plan increased automatically by 4,677,185 shares on January 1, 2025 and will increase automatically on the first day of January of each of 2022 through 2031 by the number
of shares equal to 1% of the total issued and outstanding shares of our Class A common stock as of the immediately preceding December 31 or a lower number approved by our board of directors.
|

- |
the risks, costs, and benefits to us;
|
- |
the impact on a director’s independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated;
|
- |
the extent of the related person’s interest in the transaction;
|
- |
the purpose and terms of the transaction;
|
- |
management’s recommendation with respect to the proposed related person transaction;
|
- |
the availability of other sources for comparable services or products; and
|
- |
whether the transaction is on terms comparable to those that could be obtained in an arm’s length transaction.
|
|

●
|
each of our named executive officers;
|
●
|
each of our directors or director nominees;
|
●
|
all of our directors and executive officers as a group; and
|
●
|
each stockholder known by us to be the beneficial owner of more than 5% of our outstanding shares of our Class A common stock.
|
NAME OF BENEFICIAL OWNER
|
CLASS A
|
||
OTHER 5% OR GREATER STOCKHOLDERS (1)
|
SHARES
|
%
|
|
Stellantis N.V.(2)
|
73,235,067
|
13.04%
|
|
NAMED EXECUTIVE OFFICERS & DIRECTORS
|
|||
Adam Goldstein (3)
|
36,372,347
|
6.63%
|
|
Mark Mesler (4)
|
762,290
|
*
|
|
Priya Gupta (5)
|
147,314
|
*
|
|
Eric Lentell (6)
|
149,679
|
*
|
|
Tom Muniz (7)
|
1,334,213
|
*
|
|
Tosha Perkins (8)
|
346,985
|
*
|
|
Deborah Diaz (9)
|
147,547
|
*
|
|
Fred M. Diaz (10)
|
101,372
|
*
|
|
Oscar Munoz (11)
|
441,480
|
*
|
|
Barbara Pilarski
|
‑‑
|
*
|
|
Maria Pinelli (12)
|
128,041
|
*
|
|
Michael Spellacy (13)
|
2,209,120
|
*
|
|
All Current Executive Officers & Directors as a Group (12 Persons) (14)
|
42,140,388
|
7.65%
|
*
|
Indicates ownership of less than one percent.
|



Date and Time:
June 27, 2025
12:00 p.m. Pacific Time
|
Virtual Meeting Site:
www.virtualshareholdermeeting.com/ACHR2025
|

Proposal
|
Board
Recommendation
|
Required Vote
|
Effect of
Abstentions
|
Effect of
Broker
Non-Votes
|
Page
|
1. Election of directors named in this Proxy Statement
|
For each director nominee
|
Plurality
|
None
|
None
|
20
|
2. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025
|
For |
Majority of
votes cast
|
None |
Broker has
discretion to vote
|
28 |
3. Approval, on a non-binding advisory basis, of the compensation of our named executive officers
|
For
|
Majority of votes cast
|
None
|
None
|
30
|
4. Approval of Class A Common Stock pursuant to the Stellantis Subscription Agreement
|
For
|
Majority of votes cast
|
None
|
None
|
31
|


– |
by signing and returning a new proxy card or voting instruction form dated as of a later date, in which case only your latest proxy card or voting instruction form received
prior to the Annual Meeting will be counted;
|
– |
voting again by telephone or through the Internet; or
|
– |
attending virtually and voting during the Annual Meeting (although attendance at the Annual Meeting will not, by itself, revoke a proxy).
|

|

– |
Registered Owner (you hold our common stock in your own name at our transfer agent, Continental Stock Transfer & Trust Company, or
you are in possession of stock certificates): visit https://continentalstock.com and log into your account to enroll.
|
– |
Beneficial Owner (you hold our common stock at a brokerage firm, a bank, a trustee, or a nominee): if you hold shares beneficially,
please follow the instructions provided to you by your broker, bank, trustee, or nominee.
|




